Vaccine-induced immune response to Omicron wanes substantially over time
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
On Jul. 19, 2022, the NIH announced that although COVID-19 booster vaccinations in adults elicit high levels of…
On Jul. 17, 2022, Ghana announced the preliminary finding of two cases of Marburg virus disease and if…
On Jul. 15, 2022, The largest sustained decline in childhood vaccinations in approximately 30 years has been recorded…
On Jul. 14, 2022, Moderna announced that Health Canada had approved the use of Moderna’s mRNA COVID-19 vaccine,…
On Jul 14. 2022, Aegis Sciences announced it is was authorized to begin testing for monkeypox using the…
On Jul. 13, 2022, Quest Diagnostics announced that it had announced the nationwide availability* of the company’s lab-developed…
On Jul. 13, 2022, Novavax announced that its COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) had received emergency use authorization from…
On Jul 13. 2022, Quest Diagnostics announced the nationwide availability of the company’s lab-developed molecular diagnostic test to…
On Jul. 11, 2022, Moderna announced new clinical data on its bivalent Omicron (BA.1) booster candidate, mRNA-1273.214. One…
On Jul. 11, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) launched an early-stage clinical trial…
On Jul. 8, 2022, Pfizer and BioNTech announced that the companies had submitted a variation to the European…
On Jul. 8, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the stateï¾’s…
On Jul. 8, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
On Jul. 6, 2022, LabCorp announced that it had begun testing for monkeypox using the U.S. Centers for…
On Jul. 5, 2022, Tgen and Northern Arizona University announced that a research team found that the vaccine…
On Jul. 5, 2022, the National Institutes of Health released a study that described the immune response triggered…
On Jun. 30, 2022, Pfizer and BioNTech announced a vaccine supply agreement with the U.S. government to support…
On Jun. 30, 2022, BD (Becton, Dickinson) announced that the BD MAX Respiratory Viral Panel (RVP), a new…
On Jun. 28, 2022, the National Institutes of Health (NIH) announced that a Phase 1 clinical trial of…
Play the COVID-19 Wheel of Fortune and see how lucky you are! You have two wheels to choose…
On Jun. 24 2022, Pfizer and BioNTech announced positive data evaluating the safety, tolerability, and immunogenicity of two…
On Jun. 24, 2022, Emergent BioSolutions announced that the U.S. Food and Drug Administration accepted for review the…
On Jun. 23, 2022, BioNTech announced it had reached a milestone in the establishment of scalable mRNA vaccine…
On Jun. 17, 2022, Moderna announced that it had received emergency use authorization from the U.S. Food and…
On Jun. 17, 2022, Pfizer and BioNTech announced the U.S. Food and Drug Administration had granted emergency use…
On Jun, 15, 2022, a multidisciplinary team of scientists, announced they had obtained and studied ancient Y. pestis…
On Jun. 15, 2022, Roche announced that the US Food and Drug Administration had issued Emergency Use Authorization…
On Jun. 10, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
On Jun. 10, 2022, researchers from Case Western Reserve School of Medicine, Case Comprehensive Cancer Center, and The…
On Jun. 10, 2022, CDC and public health officials in several states announced they were investigating multistate outbreaks…